Trademark search for:

TASOQLIR

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results

Also check across:

USPTO Filing History

Key events recorded for this trademark application

2022-08-11 — Application filed
2022-08-15 — Application filed
2022-08-17 — Application filed
2023-05-30 — Assigned to examiner
2023-06-01 — Suspension letter written
2023-06-01 — Letter of suspension e-mailed
2023-06-01 — Notification of letter of suspension e-mailed
2023-07-12 — Teas change of owner address received
2023-07-12 — Applicant/correspondence changes (non-responsive) entered
2023-07-12 — Teas change of correspondence received
2023-09-28 — Teas response to suspension inquiry received
2024-01-10 — Suspension checked - to attorney for action
2024-02-07 — Approved for pub - principal register
2024-02-21 — Notification of notice of publication e-mailed
2024-02-21 — Official gazette publication confirmation e-mailed
2024-03-12 — Published for opposition
2024-03-12 — Official gazette publication confirmation e-mailed
2024-05-07 — Noa e-mailed - sou required from applicant
2024-10-08 — Teas delete 1(b) basis received
2024-12-09 — Application abandoned
2024-12-09 — Application abandoned
2024-12-09 — Final status recorded

Owner Information

Glaxo Group Limited
Stevenage GB

Correspondent

Elizabeth K. Rucki GSK
410 BLACKWELL STREET
LEGAL BRAND PROTECTION
DURHAM, NC 27701

Filing Details

Filing Date:
2022-08-11

Status Date:
2024-12-09

Category:
Pharmaceuticals

Filing Year:
2022

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.